Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Revenue (2024 - 2025)

Historic Revenue for Prime Medicine (PRME) over the last 2 years, with Q3 2025 value amounting to $1.2 million.

  • Prime Medicine's Revenue rose 48612.44% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 64712.5%. This contributed to the annual value of $3.0 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Prime Medicine reported Revenue of $1.2 million as of Q3 2025, which was up 48612.44% from $1.1 million recorded in Q2 2025.
  • Prime Medicine's 5-year Revenue high stood at $2.2 million for Q4 2024, and its period low was $209000.0 during Q3 2024.